Phase I study of the combination of losoxantrone and cyclophosphamide in patients with refractory solid tumours.
Phase I study of the combination of losoxantrone and cyclophosphamide in patients with refractory solid tumours. Br J Cancer. 2002 Feb 12; 86(4):534-9.